Stephane Epelbaum

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Lost in Scheduling? A Reliable Tool for Detecting Subtle Cognitive Decline in Mild Cognitive Impairment and Mild Alzheimer's Disease.

Lost in Scheduling? A Reliable Tool for Detecting Subtle Cognitive Decline in Mild Cognitive Impairment and Mild Alzheimer's Disease.

Journal: American journal of speech-language pathology

Published: July 14, 2026

Donanemab treatment effect by baseline tau burden and disease severity: Observations from the TRAILBLAZER-ALZ 2 trial.

Donanemab treatment effect by baseline tau burden and disease severity: Observations from the TRAILBLAZER-ALZ 2 trial.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 23, 2026

Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses.

Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses.

Journal: The journal of prevention of Alzheimer's disease

Published: January 31, 2026

Sleep-like slow waves during resting-state: A promising EEG biomarker of amyloid and neurodegeneration in preclinical Alzheimer's disease.

Sleep-like slow waves during resting-state: A promising EEG biomarker of amyloid and neurodegeneration in preclinical Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 21, 2025

How can Alzheimer's disease blood-based biomarkers reach clinical practice?

How can Alzheimer's disease blood-based biomarkers reach clinical practice?

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: May 26, 2025

Depressive Symptoms and Amyloid Pathology.

Depressive Symptoms and Amyloid Pathology.

Journal: JAMA psychiatry

Published: January 22, 2025

MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study: Smartphone App for MCI Detection.

MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study: Smartphone App for MCI Detection.

Journal: The journal of prevention of Alzheimer's disease

Published: November 18, 2024

Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use.

Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use.

Journal: The journal of prevention of Alzheimer's disease

Published: October 31, 2024

Diagnostic Biomarkers of Amyloid and Tau Pathology in Alzheimer's Disease: An Overview of Tests for Clinical Practice in the United States and Europe.

Diagnostic Biomarkers of Amyloid and Tau Pathology in Alzheimer's Disease: An Overview of Tests for Clinical Practice in the United States and Europe.

Journal: The journal of prevention of Alzheimer's disease

Published: June 25, 2023

Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification.

Validation study of "Santé-Cerveau", a digital tool for early cognitive changes identification.

Journal: Alzheimer's research & therapy

Published: December 05, 2022

The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease.

The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease.

Journal: AJOB neuroscience

Published: March 09, 2022

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Journal: JAMA neurology

Published: January 31, 2022

Showing 1-12 of 90

Last Updated: 09/26/2026